SalaryGuide
SalariesCompaniesJobs
AboutPricingBlogFor Employers

Marketing jobs

3,363 marketing jobs

AtriCure logo
3 months ago

Senior Director, Product Marketing

AtriCure

Minnetonka, MN (On-site)Full time$200K/yr – $275K/yr
Microsoft logo
3 months ago

Senior Product Marketing Manager

Microsoft

Redmond, WA (Hybrid)Full time$106K/yr – $223K/yr
TikTok logo
4 months ago

Senior Global Product Marketing Manager - Search Ads

TikTok

New York City, NY (On-site)Full time$122K/yr – $288K/yr
Navan logo
4 months ago

Senior Product Marketing Manager

Navan

San Francisco, CA (On-site)Full time$130K/yr – $288K/yr
Blitzy logo
4 months ago

Technical Product Marketing Manager

Blitzy

Cambridge, MA (On-site)Full time$160K/yr – $180K/yr
LastPass logo
4 months ago

Senior Growth Product Marketing Manager

LastPass

USA (Remote)Full time$90K/yr – $100K/yr
Amphenol Communications Solutions logo
4 months ago

Lead Product Marketing Manager – Power Solutions

Amphenol Communications Solutions

Pennsylvania, USA (On-site)Full time
Clay Labs logo
5 months ago

Product Marketing (GTM)

Clay Labs

New York, USA (Hybrid)Full time$180K/yr – $230K/yr
Signal and Strand logo
5 months ago

Senior Global Product Marketing Manager

Signal and Strand

El Segundo, CA (Hybrid)Full time$150K/yr – $175K/yr
TikTok logo
6 months ago

Product Marketing Manager, TikTok Operations

TikTok

Los Angeles, CA (On-site)Full time$89K/yr – $209K/yr
Netflix logo
6 months ago

Associate Ads Product Marketing Manager

Netflix

New York, USA (On-site)Full time$161K/yr – $245K/yr
Schneider Electric logo
6 months ago

Product Marketing Manager

Schneider Electric

Nashville, TN (On-site)Full time
Qualytics logo
6 months ago

Product Marketing Manager

Qualytics

USA (Remote)Full time
Previous
1...626364...
Next

Related searches

  • Remote Product Marketing Jobs

All Product Marketing roles in the US

Get alerts for this search

All Product Marketing roles in the US

Get alerts for this search

3,363 jobs
AtriCure logo

Senior Director, Product Marketing

AtriCure

Minnetonka, MN (On-site)

$200K/yr - $275K/yrIn-houseFull-timeDirector/executive
3 months ago
Microsoft logo

Senior Product Marketing Manager

Microsoft

Redmond, WA (Hybrid)

$106K/yr - $223K/yrIn-houseFull-timeSenior level3+ years exp.
3 months ago
TikTok logo

Senior Global Product Marketing Manager - Search Ads

TikTok

New York City, NY (On-site)

$122K/yr - $288K/yrIn-houseFull-timeSenior level
4 months ago
Navan logo

Senior Product Marketing Manager

Navan

San Francisco, CA (On-site)

$130K/yr - $288K/yrIn-houseFull-timeSenior level6+ years exp.
4 months ago
Blitzy logo

Technical Product Marketing Manager

Blitzy

Cambridge, MA (On-site)

$160K/yr - $180K/yrIn-houseFull-timeSenior level6+ years exp.
4 months ago
LastPass logo

Senior Growth Product Marketing Manager

LastPass

USA (Remote)

$90K/yr - $100K/yrIn-houseFull-timeSenior level
4 months ago
Amphenol Communications Solutions logo

Lead Product Marketing Manager – Power Solutions

Amphenol Communications Solutions

Pennsylvania, USA (On-site)

In-houseFull-timeSenior level7+ years exp.
4 months ago
Clay Labs logo

Product Marketing (GTM)

Clay Labs

New York, USA (Hybrid)

$180K/yr - $230K/yrIn-houseFull-timeSenior level8+ years exp.
5 months ago
Signal and Strand logo

Senior Global Product Marketing Manager

Signal and Strand

El Segundo, CA (Hybrid)

$150K/yr - $175K/yrIn-houseFull-timeSenior level7+ years exp.
5 months ago
TikTok logo

Product Marketing Manager, TikTok Operations

TikTok

Los Angeles, CA (On-site)

$89K/yr - $209K/yrIn-houseFull-timeSenior level5+ years exp.
6 months ago
Netflix logo

Associate Ads Product Marketing Manager

Netflix

New York, USA (On-site)

$161K/yr - $245K/yrIn-houseFull-timeMid level5+ years exp.
6 months ago
Schneider Electric logo

Product Marketing Manager

Schneider Electric

Nashville, TN (On-site)

In-houseFull-timeMid level4+ years exp.
6 months ago
Qualytics logo

Product Marketing Manager

Qualytics

USA (Remote)

In-houseFull-timeMid level5+ years exp.
6 months ago
Previous1…626364…Next
AtriCure logo
AtriCure

Senior Director, Product Marketing

Minnetonka, MN (On-site)

$200K/yr – $275K/yrDirector/ExecutiveFull time

Posted 3 months ago

  • Job
  • Company
  • Salaries
  • People
  • Funding
  • Audience
  • News
  • Links

Job Summary

Own portfolio strategy and governance for Pain Management, aligning R&D, sales, and clinical stakeholders to optimize adoption and downstream revenue.

  • Lead data driven portfolio health metrics and investment prioritization.
  • Own cross functional voice with clinicians, hospitals, and KOLs to shape roadmap and launches.
  • Partner with Regulatory, Legal, and Market Access to ensure compliant, compelling value stories and field enablement.

Job Description

Own Portfolio strategy and governance for Pain Management to drive adoption, revenue growth, and patient outcomes.

  • Own and lead the overall product marketing and portfolio strategy for the Pain Management business, serving as the primary voice and champion for the therapy area across the organization.
  • Set the long term vision and growth strategy for Pain Management based on deep understanding of clinical practice, patient pathways, market dynamics, reimbursement, customer needs, and competitive landscape.
  • Own full product lifecycle and portfolio strategy across multiple pain management solutions (e.g., cardiac, thoracic, extremity), representing the portfolio in enterprise level portfolio governance, investment, and prioritization decisions.
  • Define and execute integrated product marketing strategies across the Pain Management portfolio, including value proposition development, positioning, messaging architecture, segmentation, go to market strategy, and launch excellence to drive adoption, revenue growth, and profitability.
  • Establish and champion a data driven operating culture across the portfolio by defining key business, market, and performance metrics to inform decisions, prioritize investments, and track portfolio health and impact.
  • Lead customer, clinician, and thought leader engagement across the Pain Management space, building strong partnerships with physicians, advanced practice providers, hospitals, health systems, and KOLs, and contributing to enterprise wide thought leader strategy and engagement models.
  • Guide innovation and future pipeline strategy within Pain Management by identifying unmet clinical needs, emerging technologies, evolving standards of care, and new market opportunities to inform product development and long range strategic planning.
  • Partner closely with R&D and cross functional teams to translate voice of customer, market, and clinical insights into differentiated product requirements, evidence strategies, and successful product development across the portfolio.
  • Ensure regulatory, legal, and compliance alignment in all product marketing, messaging, and portfolio planning activities, reinforcing a strong culture of compliance.
  • Collaborate with Sales, Training & Education, Market Access, and International teams to align portfolio strategy, enable the field with compelling value stories and tools, and support achievement of global revenue, adoption, and market expansion objectives.
  • Lead, develop, and mentor high performing product marketing teams responsible for multiple products and initiatives, shaping organizational design, building future leaders, and fostering a culture of accountability, innovation, and continuous improvement.
  • Develop and manage portfolio level budgets and resourcing plans, ensuring efficient allocation of people and capital to support strategic priorities and financial commitments.
  • Act as a senior enterprise leader, influencing without authority, shaping ways of working, driving cross functional alignment, and contributing to broader commercial, marketing, and corporate strategy initiatives.
  • Build and maintain portfolio governance mechanisms, ensuring cross functional alignment and timely decision making to support market access and expansion.
  • Oversee top line growth through strategic portfolio investments, prioritizing initiatives with the highest impact on payer economics and patient outcomes.
  • Foster a culture of accountability and continuous improvement across the product marketing organization.
  • Drive alignment with executives on portfolio priorities and performance through regular strategic reviews.
AtriCure logo

AtriCure

4.7 Glassdoor

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists, cardiothoracic and thoracic surgeons around the globe use AtriCure technologies for the treatment of Afib, reduction of Afib related complications and post-operative pain management. AtriCure’s Isolator® SynergyTM Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AFTM Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE®+ and cryoSPHERE MAXTM probes are cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on X (formerly Twitter) @AtriCure.

Founded in 2000
Mason, Ohio, USA
1.3K employees (88 in marketing)
www.atricure.com
94% recommend to a friend
95% CEO approval

Salaries

Posted range

$200K/yr – $275K/yr

Taken straight from the job posting.

See all AtriCure salaries

Marketing Team

Marketing Team Size
65 (5% of company)
Marketing Roles Posted (Last 30 Days)
4

Funding

Total Funding
$207M
Last Raise
$6M
Grant, 4 months ago

Funding History

  • Dec 2025
    Grant • $6M
  • May 2020
    Post IPO Equity • $175M
  • Jun 2002
    Series Unknown • $21M

Traffic Signals

Monthly Visitors
18.2K
Monthly Google Ads Budget
$2.1K
Traffic Source Mix
Search
41.3%
Direct
44.7%
Referral
7.4%
Social
4.6%
Paid
1.9%

Headcount Trend

Current headcount: ~1.3K

Recent News

AtriCure, Inc. $ATRC Shares Acquired by Squarepoint Ops LLC
Dec 15, 2025 • MarketBeat
ATRC Treats First Patients Using Novel Dual-Energy PFA-RFA Platform
Dec 12, 2025 • Finviz
AtriCure Announces the First Patients Treated with Novel Dual Energy Platform
Dec 11, 2025 • 01net
AtriCure Says First Patients Treated With Dual-Energy Platform
Dec 11, 2025 • marketscreener.com
AtriCure (ATRC) Introduces Cutting-Edge Dual Energy Platform in Initial Treatments
Dec 11, 2025 • GuruFocus
AtriCure, Inc.'s (NASDAQ:ATRC) 29% Share Price Surge Not Quite Adding Up
Dec 11, 2025 • simplywall.st
Russell Investments Group Ltd. Decreases Stake in AtriCure, Inc. $ATRC
Dec 11, 2025 • MarketBeat
AtriCure, Inc. (NASDAQ:ATRC) Given Consensus Rating of "Moderate Buy" by Brokerages
Nov 30, 2025 • MarketBeat
Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares?
Nov 29, 2025 • The Motley Fool
Insider Sell: Justin Noznesky Sells 5,166 Shares of AtriCure Inc (ATRC)
Nov 27, 2025 • GuruFocus
AtriCure director Yuen sells $107k in shares
Nov 25, 2025 • Investing.com
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year?
Nov 20, 2025 • Yahoo Finance
AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference
Nov 18, 2025 • Yahoo Finance
Why AtriCure Inc. stock attracts high net worth investors - 2025 Trade Ideas & Low Drawdown Trading Strategies
Nov 15, 2025 • newser.com
What’s the recovery path for long term holders of AtriCure Inc. - 2025 Stock Rankings & Safe Entry Trade Reports
Nov 15, 2025 • newser.com
Why AtriCure Inc. stock remains undervalued - Inflation Watch & Reliable Intraday Trade Plans
Nov 15, 2025 • newser.com
What’s the recovery path for long term holders of AtriCure Inc. - Product Launch & Technical Buy Zone Confirmation
Nov 15, 2025 • newser.com
Is AtriCure Inc. stock near bottom after decline - Treasury Yields & AI Enhanced Market Trend Forecasts
Nov 15, 2025 • newser.com
What’s the recovery path for long term holders of AtriCure Inc. - Wall Street Watch & High Accuracy Swing Entry Alerts
Nov 15, 2025 • newser.com
Advisors Capital Management LLC Has $5.54 Million Stock Holdings in AtriCure, Inc. $ATRC
Nov 15, 2025 • Defense World
How rising interest rates impact AtriCure Inc. stock - Trade Performance Summary & AI Optimized Trade Strategies
Nov 15, 2025 • newser.com
Why AtriCure Inc. stock attracts high net worth investors - 2025 Volatility Report & Safe Capital Preservation Plans
Nov 14, 2025 • newser.com
How AtriCure Inc. stock reacts to Fed rate cuts - July 2025 WrapUp & Smart Allocation Stock Reports
Nov 14, 2025 • Fundação Cultural do Pará
Why AtriCure Inc. stock could benefit from AI revolution - Treasury Yields & AI Forecast for Swing Trade Picks
Nov 14, 2025 • Fundação Cultural do Pará
What drives AtriCure Inc stock price - Swing Trading Watchlist & Free Daily Investment Newsletter Subscription
Nov 13, 2025 • earlytimes.in
Why AtriCure Inc. stock attracts high net worth investors - Trade Entry Summary & Verified Short-Term Plans
Nov 13, 2025 • newser.com
Acadian Asset Management LLC Has $6.69 Million Stock Position in AtriCure, Inc. $ATRC
Nov 13, 2025 • Defense World
What’s the recovery path for long term holders of AtriCure Inc. - 2025 Pullback Review & High Accuracy Trade Signal Alerts
Nov 13, 2025 • newser.com
Is AtriCure Inc. stock near bottom after decline - Treasury Yields & Stepwise Trade Signal Guides
Nov 13, 2025 • newser.com
How rising interest rates impact AtriCure Inc. stock - Portfolio Gains Report & Community Driven Trade Alerts
Nov 12, 2025 • newser.com
AtriCure (ATRC) Is Down 5.8% After Raising Revenue Guidance and Narrowing Net Loss – Has The Bull Case Changed?
Nov 10, 2025 • simplywall.st
Transcript : AtriCure, Inc. Presents at UBS Global Healthcare Conference 2025, Nov-10-2025 02
Nov 10, 2025 • marketscreener.com
How sustainable is AtriCure Inc. stock dividend payout - Weekly Trading Summary & Verified Momentum Watchlists
Nov 7, 2025 • newser.com
AtriCure (ATRC) Loses 13.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Nov 7, 2025 • Nasdaq
Here's What Key Metrics Tell Us About AtriCure (ATRC) Q3 Earnings (Revised)
Nov 6, 2025 • Nasdaq
Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year?
Nov 4, 2025 • Yahoo Finance
AtriCure, Inc. (NASDAQ:ATRC) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Nov 1, 2025 • simplywall.st
AtriCure, Inc. (NASDAQ:ATRC) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Nov 1, 2025 • Sahm
Taking the lead: Atricure Inc (ATRC)
Oct 31, 2025 • setenews.com
AtriCure (ATRC) Aims for Near-Term Profitability After Strong Growth Forecasts
Oct 31, 2025 • Yahoo Finance
AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial
Oct 31, 2025 • MedTech Intelligence
AtriCure, Inc. Reports Strong Q3 2025 Results
Oct 31, 2025 • The Globe and Mail
AtriCure (ATRC) Target Price Raised by Canaccord Genuity | ATRC Stock News
Oct 30, 2025 • GuruFocus
AtriCure Outpaces Forecasts With Strong Q3 Revenue Growth
Oct 30, 2025 • Finimize
AtriCure stock rises as Citizens reiterates Market Outperform rating after strong Q3
Oct 30, 2025 • Investing.com
AtriCure, Inc. SEC 10-Q Report
Oct 30, 2025 • TradingView — Track All Markets
AtriCure’s Earnings Call Highlights Robust Growth and Innovation
Oct 30, 2025 • TipRanks
AtriCure: Q3 Earnings Snapshot
Oct 29, 2025 • Daily Independent
Earnings Flash (ATRC) AtriCure, Inc. Reports Q3 Revenue $134.3M, vs. FactSet Est of $131.3M
Oct 29, 2025 • MarketScreener
AtriCure Inc reports results for the quarter ended September 30 - Earnings Summary
Oct 29, 2025 • TradingView
AtriCure (ATRC) Reports Q3 Loss, Beats Revenue Estimates
Oct 29, 2025 • Yahoo Finance
AtriCure (ATRC): Exploring Valuation After First Patient Treated in BoxX-NoAF FDA Trial
Oct 28, 2025 • Sahm
AtriCure launches first-of-its-kind clinical trial to prevent post-operative atrial fibrillation
Oct 28, 2025 • Medical Economics
AtriCure (ATRC) Kicks Off BoxX-NoAF Clinical Trial with First Pa
Oct 28, 2025 • GuruFocus
AtriCure announces the first patient treated in the BoxX-NoAF clinical trial
Oct 28, 2025 • MarketScreener
AtriCure enrolls first patient in BoxX-NoAF study
Oct 28, 2025 • MassDevice
AtriCure’s Ongoing Study: Implications for Cardiac Treatment and Market Performance
Oct 27, 2025 • TipRanks
AtriCure to Participate in Upcoming Investor Conferences
Oct 27, 2025 • Business Wire
Did Analyst Optimism After Q3 Results Just Shift AtriCure's (ATRC) Path to Profitability Narrative?
Oct 11, 2025 • simplywall.st
AtriCure to Announce Third Quarter 2025 Financial Results
Oct 8, 2025 • Business Wire
Is AtriCure's cryoXT FDA Clearance Reshaping the Investment Case for ATRC?
Sep 21, 2025 • simplywall.st
Insider Sell: Justin Noznesky Sells 3,000 Shares of AtriCure Inc (ATRC)
Sep 16, 2025 • GuruFocus
AtriCure, Inc. $ATRC Position Boosted by Acadian Asset Management LLC
Sep 14, 2025 • Defense World
AtriCure begins rollout of cryoXT cryoablation tech for post-operative pain after amputation
Sep 9, 2025 • MassDevice
Do You Believe in the Upside Potential of Atricure (ATRC)?
Sep 9, 2025 • Yahoo Finance
AtriCure (NASDAQ:ATRC) pulls back 4.2% this week, but still delivers shareholders respectable 40% return over 1 year
Sep 3, 2025 • simplywall.st
Leading Afib Treatment Innovator AtriCure to Present at Wells Fargo Healthcare Conference September 2025
Aug 20, 2025 • Stock Titan
AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference
Aug 20, 2025 • MarketScreener
AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference
Aug 20, 2025 • Business Wire
AtriCure, Inc. (ATRC) Stock Analysis: Exploring a 40% Upside Potential Driven by Strong Analyst Support
Aug 19, 2025 • DirectorsTalk Interviews
AtriCure, Inc. : Positioned for Growth in Surgical Afib Solutions
Aug 11, 2025 • MarketScreener
Left Atrial Appendage Closure Device Market Expected to Achieve a Strong 7.78% CAGR, to Reach USD 5.64 Billion by 2034
Aug 8, 2025 • EIN Presswire
AtriCure Rings the Opening Bell
Aug 1, 2025 • Nasdaq
AtriCure, Inc. (NASDAQ:ATRC) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 1, 2025 • simplywall.st
AtriCure, Inc. SEC 10-Q Report
Jul 30, 2025 • TradingView
JMP reiterates Market Outperform rating on AtriCure stock after strong Q2
Jul 30, 2025 • Investing.com
AtriCure Inc (ATRC) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Milestones
Jul 30, 2025 • Yahoo Finance
AtriCure (ATRC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Jul 29, 2025 • sharewise.com
AtriCure (ATRC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Jul 29, 2025 • Nasdaq
Earnings call transcript: AtriCure beats Q2 2025 EPS forecast, stock rises
Jul 29, 2025 • Investing.com
AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025
Jul 29, 2025 • Yahoo Finance
AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025
Jul 29, 2025 • Business Wire
AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025
Jul 29, 2025 • BioSpace
AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference
Jul 28, 2025 • BioSpace
AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference
Jul 28, 2025 • Business Wire
AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference
Jul 28, 2025 • MarketScreener
U.S. Cryoablation Probes Market Size, Share & Trends Analysis 2025-2033 | Strategic Collaborations Accelerate Expansion, Cardiac and Cancer Treatments Propel Demand
Jul 25, 2025 • Research and Markets
Pars Planitis Treatment Market Forecast To 2034 – For Business Leaders, Analysts, And Strategic Teams
Jul 24, 2025 • EIN Presswire
AtriCure completes enrollment in stroke prevention trial
Jul 15, 2025 • MassDevice
AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention
Jul 15, 2025 • Yahoo Finance
AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention
Jul 15, 2025 • MarketScreener
AtriCure (NASDAQ:ATRC) Has Debt But No Earnings; Should You Worry?
Jul 8, 2025 • simplywall.st
AtriCure to Announce Second Quarter 2025 Financial Results
Jul 8, 2025 • Business Wire
Global Electrophysiology Market and the Surge in Cardiac Procedures: Projecting a 12% CAGR to 2026
Jun 10, 2025 • PharmiWeb
Global Cardiac Ablation Market: Advancements in Minimally Invasive Procedures and 13% CAGR by 2030
Jun 4, 2025 • PharmiWeb
Left Atrial Appendage Closure Device Market projected to surpass US$ 8,786.032 million by 2030 at a CAGR of 20.39%
Jun 2, 2025 • EIN Presswire
AtriCure Inc (ATRC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Apr 30, 2025 • Yahoo Finance
AtriCure, Inc. SEC 10-Q Report
Apr 30, 2025 • TradingView
AtriCure Announces First Use of the AtriClip PRO-Mini® Device
Apr 10, 2025 • Yahoo Finance
AtriCure announces first use of newest AtriClip device
Apr 10, 2025 • MassDevice

Links

www.atricure.comLinkedInX (Twitter)Crunchbase

This role is listed on SalaryGuide for informational purposes. SalaryGuide is not the employer, recruitment agency, or hiring representative for this position. Hiring decisions and the application process are managed by the employer. SalaryGuide will never ask candidates to pay to apply for a job or request bank details or identification documents as part of an application.